4//SEC Filing
Aimmune Therapeutics, Inc. 4
Accession 0000899243-17-014692
CIK 0001631650operating
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:06 PM ET
Size
10.5 KB
Accession
0000899243-17-014692
Insider Transaction Report
Form 4
Seltzer Stacey Denenberg
Director
Transactions
- Award
Stock Option (right to buy)
2017-05-25+17,500→ 17,500 totalExercise: $18.26Exp: 2027-05-25→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2018 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001631650
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:06 PM ET
- Size
- 10.5 KB